Improving Public Health Practices and Service Delivery in the Federal Democratic Republic of Ethiopia with a Focus on HIV, Sexually Transmitted Infections, and Tuberculosis under the Presidents Emergency Plan for AIDS Relief (PEPFAR) | CDC RFA GH13 131403CONT16

Opportunity Information: Apply for CDC RFA GH13 131403CONT16

This grant opportunity is a Centers for Disease Control and Prevention (CDC) cooperative agreement designed to support ongoing work in Ethiopia to improve public health practices and the delivery of services related to HIV, sexually transmitted infections (STIs), and tuberculosis (TB) under the Presidents Emergency Plan for AIDS Relief (PEPFAR). The focus is not on launching a brand-new program, but on continuing activities that were already funded and underway through an earlier CDC funding announcement, specifically CDC-RFA-GH13-1314. In practical terms, the opportunity exists to keep previously approved partners and projects operating so they can sustain progress, maintain service coverage, and continue strengthening systems that support prevention, diagnosis, treatment, and program quality for these diseases.

The opportunity is categorized as continuation funding, meaning it is only available to organizations that were previously awarded under the original announcement. New applicants are not the intended audience for this funding. This is reinforced by the language stating the award is a continuation of funds intended only for prior grantees. While the eligibility field in the source data lists "Others," the narrative makes clear that eligibility is effectively restricted to existing awardees under the earlier CDC-RFA-GH13-1314 program. As a continuation action, the application and review process typically emphasizes performance to date, alignment with updated PEPFAR and country priorities, and the grantees capacity to carry forward planned objectives rather than proposing an entirely new scope of work.

The funding instrument type is a cooperative agreement, which generally indicates a more active role for CDC compared to a standard grant. Under cooperative agreements, CDC commonly provides substantial involvement such as technical assistance, guidance on implementation approaches, support for monitoring and evaluation, and collaboration on programmatic decisions. This is consistent with public health service delivery and systems-strengthening work where implementing partners often coordinate closely with CDC, national ministries, and other stakeholders to ensure approaches align with evidence-based practices and national strategies.

The activity category is health, and the CFDA number is 93.067, which corresponds to CDC activities tied to HIV-related public health efforts and is commonly associated with PEPFAR-supported work. The aim, as reflected in the title, is broad public health improvement in Ethiopia with emphasis on HIV, STIs, and TB, areas that are often interconnected in service delivery. In many PEPFAR contexts, this kind of program supports integrated approaches such as strengthening HIV testing and linkage to care, improving antiretroviral therapy service delivery, enhancing STI screening and management, and coordinating TB screening, diagnosis, and treatment for people living with HIV. It can also include cross-cutting health system improvements, such as laboratory strengthening, quality improvement systems, workforce training, data systems, surveillance, and program monitoring.

Several administrative details frame how the opportunity should be interpreted. The opportunity number is CDC RFA GH13 131403CONT16, signaling it is a continuation (CONT) tied back to the original GH13-1314 announcement. The original closing date listed is 2015-12-08, and the creation date is 2015-10-02, placing the continuation action within that time period. The award ceiling is listed as 0, which typically means a specific maximum amount is not published in the summary record and may be determined by factors like the existing award structure, available appropriations, annual budget negotiations, and PEPFAR country planning decisions. Expected awards are not specified in the provided data, which is also common in continuation postings because the pool of eligible recipients is already known and the number of continuations may depend on ongoing performance and available funding.

Overall, this opportunity is best understood as a mechanism for CDC to continue funding established partners already engaged in Ethiopia-based public health work under PEPFAR, specifically targeting improvements in HIV, STI, and TB-related practices and service delivery. The central takeaway is that it is not an open competition for new applicants; it is a continuation pathway intended to maintain momentum and sustain previously funded efforts aligned with CDC and PEPFAR priorities in Ethiopia.

• The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Improving Public Health Practices and Service Delivery in the Federal Democratic Republic of Ethiopia with a Focus on HIV, Sexually Transmitted Infections, and Tuberculosis under the Presidents Emergency Plan for AIDS Relief (PEPFAR)" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067.
• This funding opportunity was created on 2015-10-02.
• Applicants must submit their applications by 2015-12-08. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Eligible applicants include: Others.

Apply for CDC RFA GH13 131403CONT16

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: